🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent insights from Richard T. Lee, MD, FASCO, on Integrative Oncology! 🌱 Evidence-based approaches like these are essential for improving the quality of life for GI cancer patients. 🙌 Glad to see the stigma around cannabis finally fading. 💡 #GI25 Colorectal Cancer Alliance

🌟 Such an important topic! 🙌 Chloe E. Atreya, MD, PhD of UC San Francisco, highlighting mindfulness-based practices to support health during treatment. 💙 As a survivor, I’m grateful for ASCO and @IntegrativeOnc’s efforts to spread awareness. 🧘‍♂️🧘🧘‍♀️ #GI25 Colorectal Cancer Alliance

🔎 Check out the results of our mCRC survey! We’re at #GI25! 📌 Poster Alert: C17 ✨ Treatment Experiences & Decision-Making in Metastatic Colorectal Cancer Four amazing groups – Colorectal Cancer Alliance, BLKHLTH, COLONTOWN & Family Reach – partnered with Takeda Oncology 👏

Important work! 🙌 Aasma Shaukat, MD, MPH from NYU Grossman School of Medicine presenting on the performance of a blood-based test for colorectal cancer screening adjusted for US census age and sex distribution. Excited for the impact this could have! 💡 ASCO #GI25 Colorectal Cancer Alliance

Dr. Camilla Qvortrup’s abstract on single-cycle neoadjuvant pembrolizumab for stage I-III MMR-deficient colon cancer and the final analysis of the RESET-C study. 🧬 ASCO #GI25

Incredible work by Dr. Marwan G. Fakih at #GI25! 💥 The phase II Bot + Bal trial shows promising results for MSS multi-refractory mCRC: 👉 219 patients treated 👉 Bot + Bal outperforms SoC with prolonged responses for some patients 👉 Safe profile, 75mg dosing moving to Phase 3

Looking forward to this exciting debate! 🔥 Arvind Dasari, MD, MS & Kristen Ciombor will tackle the question: Is blood-based screening ready for the clinic? What are your thoughts? 🩸💬 #GI25 ASCO Colorectal Cancer Alliance

🚨 Update from Scott Kopetz MD Anderson Cancer Center on 🌊BREAKWATER: encorafenib + cetuximab + chemo = new standard of care for BRAF V600E-mutant metastatic colorectal cancer! ✔️ Improved tumor shrinkage ✔️Early data suggests longer survival- more follow-up is needed to confirm. #GI25

🖕 Kanye West Make this go viral.

In less than two weeks until the Colorectal Cancer Alliance #DCScopeItOut Walk! On March 23, 2025, we will be walking at The National Mall to honor those impacted by colorectal cancer! Donate to our team via the link below— impact.ccalliance.org/fundraiser/617…

If you attend our Young-Onset Colorectal Cancer Center Annual Patient & Family Forum on Sat 3/29/25, you will get this cool hat & so much more 💙 Dana-Farber's Young-Onset Colorectal Cancer Center Dana-Farber Dana-Farber News Fight Colorectal Cancer Colorectal Cancer Canada Colorectal Cancer Alliance Prevent Cancer Foundation Register below 👇

Meet our #AACR25 Social Media Ambassadors! Follow along for real-time insights, unique takes, and highlights from the AACR Annual Meeting.

🎉 Headed to #AACR2025? Find us at the Advocacy Pavilion — Booth AP23! Learn more about Project Cure CRC and how we're advancing CRC research. 💙 See you there! #ProjectCureCRC #ColorectalCancer 💙 #AACR2025 Colorectal Cancer Alliance

#AACR25 Opening ceremony! 🌟The American Association for Cancer Research is dedicated to advancing cancer research and improving patient outcomes, leading to the approval of 17 new cancer therapeutics in 2024.#AACR25 #SSP

New research from #AACR25 shows an ultrasensitive ctDNA assay could detect colorectal cancer recurrence after surgery much earlier than imaging! Exciting results shared by @Emma_Titmuss. Read more: aacr.org/about-the-aacr… Colorectal Cancer Alliance

Stop by the AACR poster session to learn more about the Colorectal Cancer Alliance #ProjectCureCRC! Section 8 - poster board #19-21! #AACR25 #SSP

Happening now: Dr. Emil Lou Emil Lou, MD, PhD, FACP presents first-in-human trial of CRISPR-edited T cells targeting CISH in metastatic #colorectalcancer at #AACR25 #SSP

BREAKTHROUGH in BRAF V600E metastatic colorectal cancer! 🌊BREAKWATER trial reveals that combining encorafenib, cetuximab, and mFOLFOX6 as first-line therapy significantly enhances patient outcomes compared to standard care. #ASCO25 Colorectal Cancer Alliance

We are at @asco presenting our poster on understanding and addressing unmet needs in CRC. Stop by poster 245 and learn more. #ASCO25 Colorectal Cancer Alliance

#ASCO25 Exercise as an intervention that can affect survival following resection of CRC. When patients ask me about whether there are special foods they can eat to improve success of treatment, I use the opportunity to focus on exercise as the ultimate form of nutrition! NEJM